CD40: A Pivotal Receptor In the Determination of Life/Death Decisions in B Lymphocytes

References

• Clark E. A. CD40: a cytokine receptor in search of a ligand. Tissue Antigens 1990; 36: 33–36
   Google Scholar
• Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989; 8: 1403–1410
   PubMed Web of Science ®Google Scholar
• Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J. P., Van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its ligand. Ann. Rev. Immunol. 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Noelle R. J., Snow E. C. T helper cell-dependent B cell activation. FASEB J. 1991; 5: 2770–2776
   PubMed Web of Science ®Google Scholar
• Parker D. C. T cell-dependent B cell activation. Annu. Rev. Immunol. 1993; 11: 331–360
   PubMed Web of Science ®Google Scholar
• Brian A. A. Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc. Natl. Acad. Sci. USA 1988; 85: 564–568
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80–82
   PubMed Web of Science ®Google Scholar
• Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked Hyper-IgM Syndrome. Cell 1993; 72: 291–300
   PubMed Web of Science ®Google Scholar
• Di Santo J. P., Bonnefoy J. Y., Gauchat J. F., Fischer A., de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541–543
   Google Scholar
• Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167–178
   PubMed Web of Science ®Google Scholar
• Xu J., Foy T. M., Laman J. D., Elliott E. A., Dunn J. J., Waldschmidt T. J., Elsemore J., Noelle R. J., Flavell R. A. Mice deficient for the CD40 Ligand. Immunity 1994; 1: 423–431
   PubMed Web of Science ®Google Scholar
• Foy T. M., Shepherd D. M., Durie F. H., Aruffo A., Ledbetter J. A., Noelle R. J. In Vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 1993; 178: 1567–1575
   PubMed Web of Science ®Google Scholar
• Foy T. M., Laman J. D., Ledbetter J. A., Aruffo A., Claassen E., Noelle R. J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 1994; 180: 157–163
   PubMed Web of Science ®Google Scholar
• Banchereau J., Depaoli P., Valle A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70–72
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Joshua D. E., Williams G. T., Smith C. A., Gordon J., and Mac, Lennan I. C. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Saeland S., Duvert V., Caux C., Pandrau D., Favre C., Valle A., Durand I., Charbord P., De Vries J., Banchereau J. Distribution of surface-membrane molecules on bone marrow and cord blood CD34 + hematopoietic cells. Exp. Hematol. 1992; 20: 24–33
   PubMed Web of Science ®Google Scholar
• Hasbold J., Johnson-Leger C., Atkins C. J., Clark E. A., Klaus G. G.B. Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 1994; 24: 1835–1842
   PubMedGoogle Scholar
• Van den Berg T. K., Hasbold J., Renardel de Lavallette C., Dopp E. A., Dijkstra C. D., Klaus G. G.B. Immunology 1996, in press
   Google Scholar
• Wheeler K., Pound J. D., Jefferis R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 1993; 23: 1165–1168
   Google Scholar
• Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y. J. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720–722
   PubMed Web of Science ®Google Scholar
• Maliszewski C. R., Grabstein K., Fanslow W. C., Armitage R., Spriggs M. K., Sato T. A. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 1993; 23: 1044–1049
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Maliszewski C. R., Shanebeck K., Sato T. A., Spriggs M. K., Fanslow W. C., Armitage R. J. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 1993; 150: 3141–3147
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989; 46: 111–147
   PubMed Web of Science ®Google Scholar
• Snapper C. M., Mond J. J. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 1993; 14: 15–17
   PubMedGoogle Scholar
• Germann T., Bongartz M., Dlugonska H., Hess H., Schmitt E., Kolbe L., Kolsch E., Podlaski F. J., Gately M. K., Rude E. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 1995; 25: 823–829
   PubMed Web of Science ®Google Scholar
• Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Beckman M. P., Park L. S., Schooley K. A., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 1990; 8: 303–333
   PubMed Web of Science ®Google Scholar
• Mond J. J., Finkelman F. D., Sarma C., Ohara J., Serrate S. Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J. Immunol. 1985; 135: 2513–2517
   Google Scholar
• Sidman C. L., Marshall J. D., Schultz L. D., Gray P. W., Johnson H. M. Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature 1984; 309: 801–803
   PubMed Web of Science ®Google Scholar
• Abed N. S., Chace J. H., Fleming A. L., Cowdery J. S. Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cell Immunol. 1994; 153: 356–366
   PubMed Web of Science ®Google Scholar
• Choi M. S.K., Brines R. D., Holman M. J., Klaus G. G.B. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 Ligand in conjunction with IL-4. Immunity 1994; 1: 179–187
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Macduff B. M., Spriggs M. K., Fanslow W. C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 1993; 150: 3671–3680
   PubMed Web of Science ®Google Scholar
• Peitsch M. C., Jongeneel C. V. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 1993; 5: 233–238
   PubMed Web of Science ®Google Scholar
• Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76: 959–962
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Schieven G. L., Dibirdik I., Chandan-Langlie M., Tuel-Ahlgren L., Ledbetter J. A. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 1991; 266: 17478–17485
   PubMed Web of Science ®Google Scholar
• Knox K. A., Gordon J. Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 1993; 23: 2578–2584
   PubMed Web of Science ®Google Scholar
• Faris M., Gaskin F., Parsons J. T., Man Fu S. CD40 Signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of Tyrosine-phosphorylated proteins including protein Tyrosine Kinase Lyn, Fyn, and Syk and the appearance of a 28-kD Tyrosine phosphorylated protein. J. Exp. Med. 1994; 179: 1923–1931
   PubMed Web of Science ®Google Scholar
• Ren C. L., Morio T., Fu S. M., Geha R. S. Signal transduction via CD40 invloves activation of lyn Kinase and Phosphatidylinositol-3-kinase, and phosphorylation of Phospholipase Cγ2. J. Exp. Med. 1994; 179: 673–680
   PubMed Web of Science ®Google Scholar
• Clark E. A., Shu G. L., Luscher B., Draves K. E., Banchereau J., Ledbetter J. A., Valentine M. A. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals. J. Immunol. 1989; 143: 3873–3880
   PubMed Web of Science ®Google Scholar
• Gruber M. F., Bjorndahl J. M., Nakamura S., Fu S. M. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies. J. Immunol. 1989; 142: 4144–4152
   PubMed Web of Science ®Google Scholar
• Berberich I., Shu G. L., Clark E. A. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J. Immunol. 1994; 153: 4357–4366
   PubMed Web of Science ®Google Scholar
• Inui S., Kaisho T., Kikutani H., Stamenkovic I., Seed B., Clark E. A., Kishimoto T. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 1990; 20: 1747–1753
   PubMed Web of Science ®Google Scholar
• Sato T., Irie S., Reed J. C. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 1995; 358: 113–118
   PubMedGoogle Scholar
• Hu H. M., O'Rourke K., Boguski M. S., Dixit V. M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 1994; 269: 30069–30072
   PubMed Web of Science ®Google Scholar
• Cheng G., Cleary A. M., Ye Z. S., Hong D. I., Lederman S., Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 1995; 267: 1494–1498
   PubMed Web of Science ®Google Scholar
• Rothe M., Sarma V., Dixit V. M., Goeddel D. V. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995; 269: 1424–1426
   PubMed Web of Science ®Google Scholar
• Klaus G. G.B., Choi M. S.K., Holman M. Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway. Eur. J. Immunol. 1994; 24: 3229–3232
   Google Scholar
• Klaus G. G.B. Cyclosporine-sensitive and cyclosporine-insensitive modes of B cell stimulation. Transplantation 1988; 46: 11S–14S
   PubMed Web of Science ®Google Scholar
• Rao A. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol. Today 1994; 15: 274–281
   PubMedGoogle Scholar
• Francis D. A., Karras J. G., Ke X.-Y., Sen R., Rothstein T. L. Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 1995; 7: 151–161
   PubMed Web of Science ®Google Scholar
• Lalmanach Girard A. C., Chiles T. C., Parker D. C., Rothstein T. L. T cell-dependent induction of Nf-kB in B cells. J. Exp. Med. 1993; 177: 1215–1219
   Google Scholar
• Burdin N., Van Kooten C., Galibert L., Abrams J. S., Wijdenes J., Banchereau J., Rousset F. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 1995; 154: 2533–2544
   PubMed Web of Science ®Google Scholar
• Vercelli D., Jabara H. H., Arai K., Yokota T., Geha R. Endogenous interleukin 6 plays an obligatory role in inter-leukin 4-dependent human IgE synthesis. Eur. J. Immunol. 1989; 19: 1419–1424
   PubMedGoogle Scholar
• Jabara H. H., Fu S. M., Geha R. S., Vercelli D. CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and Interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 1990; 172: 1861–1864
   PubMed Web of Science ®Google Scholar
• Worm M., Geha R. S. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int. Immunol. 1994; 6: 1883–1890
   PubMed Web of Science ®Google Scholar
• Boussiotis V. A., Nadler L. M., Strominger J. L., Goldfeld A. E. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. USA 1994; 91: 7007–7011
   PubMed Web of Science ®Google Scholar
• Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 1992; 10: 267–293
   PubMed Web of Science ®Google Scholar
• MacLennan I. C. Germinal centers. Annu. Rev. Immunol. 1994; 12: 117–139
   PubMed Web of Science ®Google Scholar
• Benhamou L. E., Cazenave P. A., Sarthou P. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 1990; 20: 1405–1408
   PubMed Web of Science ®Google Scholar
• Hasbold J., Klaus G. G.B. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 1990; 20: 1685–1690
   PubMed Web of Science ®Google Scholar
• Tsubata T., Wu J., Honjo T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993; 364: 645–648
   PubMed Web of Science ®Google Scholar
• Choi M. S.K., Boise L. H., Gottschalk A. R., Quintans J., Thompson C. B., Klaus G. G.B. The role of bcl-xL in CD40-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 1995; 25: 1352–1357
   PubMed Web of Science ®Google Scholar
• Cory S. Regulation of lymphocyte survival by the BCL-2 gene family. Annu. Rev. Immunol. 1995; 13: 513–543
   PubMed Web of Science ®Google Scholar
• Cuende E., Ales Martinez J. E., Ding L., Gonzalez Garcia M., Martinez C., Nunez G. Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J. 1993; 12: 1555–1560
   PubMed Web of Science ®Google Scholar
• Gottschalk A. R., Mc Shan C. L., Merino R., Nunez G., Quintans J. Physiological cell death in B lymphocytes: 1. Differential susceptibility of WEHI-231 sublines to anti-Ig induced physiological cell death and lack of correlation with bcl-2 expression. Int. Immunol. 1994; 6: 121–130
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gottschalk A. R., Quintans J., Thompson C. B. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top. Microbiol. Immunol. 1995; 200: 107–121
   PubMedGoogle Scholar
• Boise L. H., Gonzalez Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., Thompson C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Wang Z., Karras J. G., Howard R. G., Rothstein T. L. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 1995; 155: 3722–3725
   PubMedGoogle Scholar
• Lam M., Dubyak G., Chen L., Nunez G., Miesfeld R. L., Distelhorst C. W. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. USA 1994; 91: 6569–6573
   PubMed Web of Science ®Google Scholar
• Lam E. W.-F., La Thangue N. B. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 1994; 6: 859–866
   PubMed Web of Science ®Google Scholar
• Joseph L. F., Ezhevsky S., Scott D. W. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell Growth Differ. 1995; 6: 51–57
   Google Scholar
• Warner G. L., Ludlow J. W., Nelson D. A., Gaur A., Scott D. W. Antiimmunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. Cell Growth Differ. 1992; 3: 175–181
   PubMedGoogle Scholar
• Hijmans E. M., Voorhoeve P. M., Beijersbergen R. L., Veer L. J., Bernards R. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 1995; 15: 3082–3089
   PubMedGoogle Scholar
• Vairo G., Livingston D. M., Ginsburg D. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 1995; 9: 869–881
   PubMed Web of Science ®Google Scholar
• Illera V. A., Perandones C. E., Stunz L. L., Mower D. A., Ashman R. F. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 1993; 151: 2965–2973
   PubMed Web of Science ®Google Scholar
• Parry S. L., Hasbold J., Holman M., Klaus G. G.B. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 1994; 152: 2821–2829
   PubMed Web of Science ®Google Scholar
• Parry S. L., Holman M. J., Hasbold J., Klaus G. G.B. Plastic-immobilized antimu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 1994; 24: 974–979
   PubMed Web of Science ®Google Scholar
• Strasser A. Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr. Opin. Immunol. 1995; 7: 228–234
   PubMed Web of Science ®Google Scholar
• Watanabe D., Suda T., Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 1995; 7: 1949–1956
   PubMed Web of Science ®Google Scholar
• Mandik L., Nguyen K.-A., Erikson J. Fas receptor expression on B-lineage cells. Eur. J. Immunol. 1995; 25: 3148–3154
   PubMed Web of Science ®Google Scholar
• Rathmell J. C., Cooke M. P., Ho W. Y., Grein J., Townsend S. E., Davis M. M., Goodnow C. C. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995; 376: 181–183
   PubMed Web of Science ®Google Scholar
• Rothstein T. L., Wang J. K., Panka D. J., Foote L. C., Wang Z., Stanger B., Cui H., Ju ST., Marshak Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374: 163–165
   PubMed Web of Science ®Google Scholar
• Merino R., Ding L., Veis D. J., Korsmeyer S. J., Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 1994; 13: 683–691
   PubMed Web of Science ®Google Scholar
• Choi M. S.K., Holman M., Atkins C. J., Klaus G. G.B. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 1996
   Google Scholar
• Ohta K., Iwai K., Kasahara Y., Taniguchi N., Krajewski S., Reed J. C., Miyawaki T. Immunoblot analysis of cellular expression of Bcl-2 family proteins, Bcl-2, Bax, Bcl-X and Mcl-1, in human peripheral blood and lymphoid tissues. Int. Immunol. 1995; 7: 1817–1825
   PubMed Web of Science ®Google Scholar
• Veis D. J., Sorensen C. M., Shutter J. R., Korsmeyer S. J. Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229–240
   PubMed Web of Science ®Google Scholar
• Nakayama K., Negishi I., Kuida K., Shinkai Y., Louie M. C., Fields L. E., Lucas P. J., Stewart V., Alt F. W., et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993; 261: 1584–1588
   PubMed Web of Science ®Google Scholar
• Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267: 1506–1510
   PubMed Web of Science ®Google Scholar
• Kinnon C., Hinshelwood S., Levinsky R. J., Lovering R. C. X-linked agammaglobulinemia - gene cloning and future prospects. Immunol. Today 1993; 14: 554–558
   PubMedGoogle Scholar
• Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 1982; 33: 1–71
   PubMedGoogle Scholar
• Santos Argumedo L., Lund F. E., Heath A. W., Solvason N., Wu W. W., Grimaldi J. C., Parkhouse R. M., Howard M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int. Immunol. 1995; 7: 163–170
   Google Scholar
• Thomas J. D., Sideras P., Smith C. I.E., Vorechovsky I., Chapman V., Paul W. E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993; 261: 355–358
   PubMed Web of Science ®Google Scholar
• Rawlings D. J., Saffran D. C., Tsukada S., Largaespada D. A., Grimaldi J. C., Cohen L., Mohr R. N., Bazan J. F., Howard M., Copeland N. G., Jenkins N. A., Witte O. N. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261: 358–361
   PubMed Web of Science ®Google Scholar
• Hasbold J., Klaus G. G.B. B cells from CBA/N mice do not proliferate following ligation of CD40. Eur. J. Immunol. 1994; 24: 152–157
   PubMedGoogle Scholar
• Mond J. J., Schaefer M. E., Smith J., Finkelman F. D. Lyb-5-B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. J. Immunol. 1983; 31: 2107–2109
   Google Scholar